Synthesis, Bioevaluation and Molecular Dynamic Simulation Studies of Dexibuprofen-Antioxidant Mutual Prodrugs

Ashraf, Zaman; Alamgeer; Rasool, Raqiqatur; Hassan, Mubashir; Ahsan, Haseeb; Afzal, Samina; Afzal, Khurram; Hongsik Cho; Song Ja Kim
December 2016
International Journal of Molecular Sciences;Dec2016, Vol. 17 Issue 12, p2151
Academic Journal
Dexibuprofen-antioxidant conjugates were synthesized with the aim to reduce its gastrointestinal effects. The esters analogs of dexibuprofen 5a-c were obtained by reacting its -COOH group with chloroacetyl derivatives 3a-c. The in vitro hydrolysis data confirmed that synthesized prodrugs 5a-c were stable in stomach while undergo significant hydrolysis in 80% human plasma and thus release free dexibuprofen. The minimum reversion was observed at pH 1.2 suggesting that prodrugs are less irritating to stomach than dexibuprofen. The anti-inflammatory activity of 5c (p < 0.001) is more significant than the parent dexibuprofen. The prodrug 5c produced maximum inhibition (42.06%) of paw-edema against egg-albumin induced inflammation in mice. Anti-pyretic effects in mice indicated that prodrugs 5a and 5b showed significant inhibition of pyrexia (p < 0.001). The analgesic activity of 5a is more pronounced compared to other synthesized prodrugs. The mean percent inhibition indicated that the prodrug 5a was more active in decreasing the number of writhes induced by acetic acid than standard dexibuprofen. The ulcerogenic activity results assured that synthesized prodrugs produce less gastrointestinal adverse effects than dexibuprofen. The ex vivo antiplatelet aggregation activity results also confirmed that synthesized prodrugs are less irritant to gastrointestinal mucosa than the parent dexibuprofen. Molecular docking analysis showed that the prodrugs 5a-c interacts with the residues present in active binding sites of target protein. The stability of drug-target complexes is verified by molecular dynamic simulation study. It exhibited that synthesized prodrugs formed stable complexes with the COX-2 protein thus support our wet lab results. It is therefore concluded that the synthesized prodrugs have promising pharmacological activities with reduced gastrointestinal adverse effects than the parent drug.


Related Articles

  • GASTROHEPATIC DISORDERS.  // MPR - Pediatricians' Edition;Fall/Winter2013, Vol. 24 Issue 2, p38 

    The article offers information on several drugs for the treatment of gastrohepatic disorders including colorectal disorders, constipation, and ulcers. It says that the adverse reactions of pentasa from pharmaceutical firm Shire are headache, dyspepsia, and rash. It mentions that fleet enema firm...

  • GASTROINTESTINAL TRACT.  // Physician Assistants' Prescribing Reference;Winter2010, Vol. 17 Issue 4, p167 

    The article offers information on several drugs that are used to treat and manage gastrointestinal tract disorders. The drugs include Bentyl from Axcan Pharma Inc., Amoxil from GlaxoSmithKline, and Biaxin from Abbott. Moreover, the article provides the prescribing notes, classification,...

  • SECTION 9 GASTROINTESTINAL TRACT.  // MPR - Residents' Edition;Fall/Winter2009, Vol. 18 Issue 2, p112 

    The article offers information on several drugs for treating gastrointestinal tract disorders including Aciphex from Pricara, Amoxil from GlaxoSmithKline, and Carafate from Axcan Pharma Inc. An overview of their adverse reactions, contraindications, uses, and interactions is provided. In...

  • Drugs for selected GI disorders.  // Formulary;Jun2000, Vol. 35 Issue 6, p544 

    Presents drugs recommended for gastrointestinal (GI) disorders. Balsalazide disodium; Cilansetron; Esomeprazole; Fedotozine.

  • Adalimumab/etanercept/infliximab.  // Reactions Weekly;4/17/2010, Issue 1297, p7 

    The article describes 41 cases of cutaneous events among patients with gastroenterological disorders during anti-tumor necrosis factor (TNF)-α therapy using adalimumab, etanercept and infliximab. It outlines the cutaneous symptoms experienced by the patients. A description of the...

  • Doxycycline.  // Reactions Weekly;2/20/2016, Vol. 1589 Issue 1, p91 

    An abstract of the article "Doxycycline induced gastrointestinal injury: Case series with new sites of involvement" by K. Affolter and others is presented.

  • THE DRUG INTERACTIONS WE ALL OVERLOOK. Rodman, Morton J. // RN;Dec80, Vol. 43 Issue 12, p58 

    Part IV. Discusses the clinical consequences of five different over-the-counter gastro-intestinal remedies when taken with prescription drugs. Antidiarrheals; Antiemetics; Cathartics; Charcoal; Laxatives.

  • THE CLINICAL EVALUATION OF A NEW LONG-ACTING ANTICHOLINERGIC DRUG. Hecht, Arthur // American Journal of Gastroenterology;Aug1960, Vol. 34 Issue 2, p179 

    Presents a study which evaluated the efficacy of anticholinergic drugs in the prolonged suppression of gastric secretion in man. Components of the anticholinergic drugs SG1 and SG2 used in the study; Degree of gastric acidity in the patients studied; Side effects of SG1 and SG2.

  • Pirenzepine. Levinson, Robert A. // American Journal of Gastroenterology;Nov1983, Vol. 78 Issue 11, p765 

    Discusses the use of the anti ulcer drug pirenzepine in the treatment of gastrointestinal disorders. Background on the development of pirenzepine; Effect of pirenzepine on gastric acidity; Results of psychopharmacological studies of the drug.

  • KINETIC STUDY OF THE IN VITRO RELEASE AND STABILITY OF THEOPHYLLINE FLOATING BEADS. AHMED, OSAMA A. A.; BADR-ELDIN, SHAIMAA M.; AHMED, TAREK A. // International Journal of Pharmacy & Pharmaceutical Sciences;Jan-Mar2013, Vol. 5 Issue 1, p179 

    Theophylline floating beads have been investigated as a possible gastro-retentive dosage forms. Emulsion gelation method was used in the preparation of oil entrapped floating alginate beads. Drug content and floating properties of the prepared beads were determined. The data obtained from the in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics